ADIPOQ and metabolic disease: Nonetheless, using a Mendelian randomization approach, a recent study did not support a causal relationship between reduced circulating adiponectin levels and two obesity-related metabolic disorders, i.e., insulin sensitivity and type 2 diabetes mellitus.